Latest news
Loading news…
Prolifagen
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Philadelphia, Pennsylvania, United States Founded 2016 1-10 employees For Profit
Prolifagen develops microRNA-based therapies for cardiac regeneration, aiming to prevent heart failure.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 26
- IT spend
- $40K
Company Info
- Founded
- 2016
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 3
- News articles
- 1
- HQ
- Philadelphia, Pennsylvania, United States
- Region
- Greater Philadelphia Area, Great Lakes, Northeastern US
Signals & Scores
- Heat score
- High
- Growth score
- High
- Trend (7d)
- 0.7
- Trend (30d)
- 2.5
- Trend (90d)
- 1.1
- Last leadership hire
- Sep 13, 2022
Key People at Prolifagen
Founder
Founder
Co-Founder & Chairman
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Prolifagen
Loading news…
FAQs about Prolifagen
People who checked this page also checked these
Browse the full Acquirezy directory.